HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Yao Selected Research

Splenic Neoplasms (Cancer, Splenic)

1/2018Paeoniflorin inhibits VSMCs proliferation and migration by arresting cell cycle and activating HO-1 through MAPKs and NF-κB pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Yao Research Topics

Disease

56Neoplasms (Cancer)
03/2022 - 01/2004
21Breast Neoplasms (Breast Cancer)
01/2022 - 01/2004
17Inflammation (Inflammations)
01/2022 - 11/2016
11Neoplasm Metastasis (Metastasis)
03/2022 - 11/2005
6Glioma (Gliomas)
09/2021 - 08/2018
6Infections
03/2021 - 11/2006
6Leukemia
03/2011 - 04/2003
5Lymphatic Metastasis
07/2015 - 01/2004
4Acute Lung Injury
01/2022 - 06/2018
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2004
4Body Weight (Weight, Body)
10/2020 - 01/2015
4Necrosis
04/2020 - 08/2006
4Birth Weight (Birth Weights)
10/2008 - 10/2005
3Osteoarthritis
12/2022 - 12/2019
3Wounds and Injuries (Trauma)
12/2021 - 07/2010
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2020
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2020 - 01/2019
3Carcinogenesis
12/2019 - 01/2006
3Hypoxia (Hypoxemia)
01/2019 - 12/2012
3Autosomal Dominant Polycystic Kidney (ADPKD)
01/2017 - 01/2016
2Synovial Sarcoma (Synovioma)
02/2022 - 01/2021
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 09/2020
2Obesity
01/2022 - 01/2020
2Acute Kidney Injury (Acute Renal Failure)
10/2021 - 04/2019
2Carcinoma (Carcinomatosis)
01/2021 - 01/2006
2Sarcoma (Soft Tissue Sarcoma)
01/2021 - 12/2013
2Pancreatitis
12/2020 - 10/2020
2Colitis
01/2020 - 10/2019
2Lung Injury
02/2019 - 01/2013

Drug/Important Bio-Agent (IBA)

23Pharmaceutical PreparationsIBA
01/2022 - 01/2004
14Proteins (Proteins, Gene)FDA Link
03/2021 - 10/2003
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 07/2004
6LipopolysaccharidesIBA
01/2022 - 06/2018
6Glucose (Dextrose)FDA LinkGeneric
03/2021 - 08/2007
6Messenger RNA (mRNA)IBA
01/2021 - 11/2005
6Liposomes (Liposome)IBA
07/2020 - 08/2006
5EnzymesIBA
01/2021 - 04/2012
5Therapeutic UsesIBA
01/2020 - 07/2004
5MicellesIBA
01/2020 - 01/2017
5Oxygen (Dioxygen)IBA
01/2019 - 11/2004
4CytokinesIBA
03/2022 - 07/2010
4Phosphotransferases (Kinase)IBA
03/2022 - 10/2003
4LipidsIBA
12/2021 - 01/2016
4BilirubinIBA
10/2021 - 01/2020
4MicroRNAs (MicroRNA)IBA
06/2021 - 10/2009
4Biological ProductsIBA
02/2021 - 12/2011
4Polylactic Acid-Polyglycolic Acid CopolymerIBA
01/2021 - 11/2017
4Matrix Metalloproteinases (MMPs)IBA
01/2021 - 10/2017
4Epirubicin (Ellence)FDA LinkGeneric
01/2018 - 05/2004
3HydrogelsIBA
12/2021 - 01/2020
3Disulfiram (Antabuse)FDA Link
09/2021 - 06/2018
3AntioxidantsIBA
01/2021 - 11/2017
3Blood Glucose (Blood Sugar)IBA
10/2020 - 01/2015
3Interleukin-6 (Interleukin 6)IBA
04/2020 - 01/2019
3fraxinIBA
02/2020 - 11/2017
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2019 - 01/2016
3Paclitaxel (Taxol)FDA LinkGeneric
12/2018 - 01/2017
3EndostatinsIBA
01/2018 - 03/2012
3Docetaxel (Taxotere)FDA Link
01/2018 - 03/2012
3Transcription Factors (Transcription Factor)IBA
03/2014 - 02/2009
3SolutionsIBA
03/2013 - 08/2006
3Small Interfering RNA (siRNA)IBA
03/2011 - 03/2007
3SuspensionsIBA
05/2008 - 04/2005
2alantolactoneIBA
03/2022 - 01/2021
2Hyaluronic Acid (Hyaluronan)IBA
03/2022 - 10/2021
2Amino AcidsFDA Link
03/2022 - 01/2020
2GhrelinIBA
01/2022 - 01/2020
2PalmitatesIBA
01/2022 - 01/2018
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2022 - 01/2016
2Long Noncoding RNAIBA
01/2022 - 01/2020
2Nanoparticle Drug Delivery SystemIBA
12/2021 - 06/2018
2IonsIBA
09/2021 - 11/2017
2Antineoplastic Agents (Antineoplastics)IBA
09/2021 - 04/2005
2Sirtuin 1IBA
03/2021 - 10/2020
2Caspase 3 (Caspase-3)IBA
03/2021 - 10/2020
2Estrogen ReceptorsIBA
01/2021 - 01/2006
2Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 12/2011
2Cadherins (E-Cadherin)IBA
01/2021 - 01/2006
2Polysaccharides (Glycans)IBA
01/2021 - 10/2020
2didyminIBA
12/2020 - 10/2018
2Streptozocin (Streptozotocin)FDA Link
10/2020 - 01/2015
2Retinaldehyde (Retinal)IBA
10/2020 - 03/2012
2Lysine (L-Lysine)FDA Link
07/2020 - 01/2020
2Glutathione PeroxidaseIBA
04/2020 - 01/2015
2Malondialdehyde (Propanedial)IBA
04/2020 - 01/2015
2Superoxide DismutaseIBA
04/2020 - 01/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2020 - 07/2019
2Anti-Bacterial Agents (Antibiotics)IBA
10/2019 - 09/2010
2Carnitine (L-Carnitine)FDA LinkGeneric
12/2018 - 11/2017

Therapy/Procedure

34Therapeutics
12/2022 - 10/2003
15Drug Therapy (Chemotherapy)
01/2022 - 01/2004
5Aftercare (After-Treatment)
11/2018 - 11/2005
5Neoadjuvant Therapy
07/2015 - 08/2007
4Intravenous Administration
07/2020 - 11/2005
3Photothermal Therapy
01/2021 - 12/2019
3Islets of Langerhans Transplantation
02/2020 - 01/2019
3Transplantation
02/2020 - 04/2003
3Subcutaneous Injections
07/2015 - 02/2005
2Biological Therapy
03/2021 - 12/2011
2Lasers (Laser)
01/2021 - 08/2018